Clinical Account Executive
Lucence
Summary
As a Clinical Accounts Executive, you will serve as the primary link between Lucence's pioneering liquid biopsy technology and the oncology community. You will be responsible for driving market adoption by articulating the clinical value of our services to key stakeholders, ensuring innovative diagnostic insights reach the clinicians and patients who need them most.
Job description
About the Role
As a Clinical Accounts Executive, you will serve as the primary link between Lucence's pioneering liquid biopsy technology and the oncology community. You will be responsible for driving market adoption by articulating the clinical value of our services to key stakeholders, ensuring innovative diagnostic insights reach the clinicians and patients who need them most.
Key Responsibilities
- Selling oncology services and products within cancer centers and community oncologists.
- Establishing a business plan and developing opportunities to achieve/exceed sales goals and revenue targets.
- Developing and maintaining relationships/partnerships with Key Opinion Leaders (KOLs), academic and community cancer centers, community oncology clinics and hospitals within designated regions.
- Maintaining strong relationships and customer satisfaction for new and existing clients.
- Providing billing/reimbursement support as relevant for patients, practices and hospital customers.
- Implementing laboratory services or other relevant agreements.
- Providing meeting and tradeshow support as relevant.
- Providing regular updates of best practices, industry trends, competitive products and services, as well as highlighting reimbursement/billing challenges.
Role Requirements
- At least a Bachelor's degree in life science, biology, business or marketing.
- At least 5 years of experience working with major cancer centers and clinics, oncology Group Purchasing Organisation (GPOs), large health systems, International Health & Development Networks (IHDNs), and large oncology practices.
- Proven track record and examples of exceeding sales goals.
- Knowledge of the local oncology market, molecular diagnostics, personalized medicine and reimbursement.
- Flexibility to perform overnight travel as needed.
- The ability to juggle multiple accounts at a time while maintaining sharp attention to details.
- Excellent listening, negotiation and presentation skills. Solid consultative selling and objection-handling skills with an ability to uncover an opportunity and deliver the solution.
- A high level of integrity, thoughtfulness and discretion in handling confidential information and interacting with customers.
- A positive attitude and appreciation for a growing start-up environment with the willingness to deliver client feedback to Lucence management on a regular basis.
- Self-motivation in driving results with minimal supervision.
- Proficiency in Microsoft Office products and Salesforce CRM.
Requirements
- Bachelor's degree in life science, biology, business or marketing
- At least 5 years of experience working with major cancer centers and clinics, oncology GPOs, large health systems, IHDNs, and large oncology practices
- Proven track record of exceeding sales goals
- Knowledge of the local oncology market, molecular diagnostics, personalized medicine and reimbursement
- Flexibility to perform overnight travel as needed
- Ability to juggle multiple accounts while maintaining sharp attention to detail
- Excellent listening, negotiation and presentation skills
- Solid consultative selling and objection-handling skills
- High level of integrity, thoughtfulness and discretion
- Positive attitude and appreciation for a growing start-up environment
- Self-motivation in driving results with minimal supervision
- Proficiency in Microsoft Office products and Salesforce CRM
Benefits
- Professional Development Budget
- Annual Leave
- Parent-Care Leave
Company overview
Lucence is a pioneering precision oncology company that specializes in developing and commercializing advanced liquid biopsy technologies for cancer detection and treatment. Founded in 2016 as a spin-off from Singapore's Agency for Science, Technology and Research (A*STAR), the company operates dual headquarters in Palo Alto, California and Singapore. Lucence's core technology revolves around its proprietary AmpliMark™ sequencing platform, which enables ultrasensitive detection of circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA) from blood samples. The company's flagship product, LiquidHALLMARK®, represents a breakthrough in liquid biopsy testing, combining DNA and RNA analysis to provide comprehensive genomic profiling for cancer patients. This Medicare-covered test helps oncologists identify clinically relevant biomarkers and match patients to targeted therapies and clinical trials. Lucence operates twin CLIA-licensed and CAP-accredited laboratories in both the United States and Singapore, serving a global patient population. The company has established strategic collaborations with leading institutions including Mayo Clinic Laboratories, expanding access to its innovative testing solutions. Beyond cancer therapy selection, Lucence has expanded into multi-cancer early detection with its LucenceINSIGHT™ test and recently launched CardioHemeRISK™ for cardiovascular risk assessment, demonstrating its commitment to transforming healthcare through non-invasive molecular diagnostics.